Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001203497 | SCV001374665 | likely benign | Landau-Kleffner syndrome | 2024-05-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002561129 | SCV003565675 | uncertain significance | Inborn genetic diseases | 2021-01-08 | criteria provided, single submitter | clinical testing | The c.3311C>T (p.T1104I) alteration is located in exon 14 (coding exon 12) of the GRIN2A gene. This alteration results from a C to T substitution at nucleotide position 3311, causing the threonine (T) at amino acid position 1104 to be replaced by an isoleucine (I). The p.T1104I alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |